In an aforementioned study, bacterial SCFAs metabolites showed steady‐state NLRP3 inflammasome activation and IL‐18 production in epithelial cells, leading to regulation of the microbiome composition, reduction of inflammatory responses and a protective effect against colitis [70]. Here, NLRP3 is linked to colitis.